Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernhard Ellinger

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Expert Opinion on Drug Discovery|February 20, 2016
Risk mitigation in academic drug discoveryBernhard Ellinger, Philip Gribbon
Chembiochem : a European Journal of Chemical Biology|December 17, 2008
A fluorescent probe for the 70 S-ribosomal GTPase-associated centerSebastian Schoof, Sascha Baumann, Bernhard Ellinger, et al.
Angewandte Chemie (International Ed. in English)|April 21, 2007
Generation of live-cell microarrays by means of DNA-Directed immobilization of specific cell-surface ligandsHendrik Schroeder, Bernhard Ellinger, Christian F W Becker, et al.
Bioorganic & Medicinal Chemistry|March 7, 2008
ATP competitive inhibitors of D-alanine-D-alanine ligase based on protein kinase inhibitor scaffoldsGemma Triola, Stefan Wetzel, Bernhard Ellinger, et al.
Journal of the American Chemical Society|February 13, 2010
Synthesis and structure-activity correlation of natural-product inspired cyclodepsipeptides stabilizing F-actinRené Tannert, Lech-Gustav Milroy, Bernhard Ellinger, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 1, 2022
High-throughput drug screening allowed identification of entry inhibitors specifically targeting different routes of SARS-CoV-2 Delta and Omicron/BA.1Maria Kuzikov, Jannis Woens, Andrea Zaliani, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2011
Biology-oriented synthesis of a natural-product inspired oxepane collection yields a small-molecule activator of the Wnt-pathwaySudipta Basu, Bernhard Ellinger, Stefano Rizzo, et al.
Journal of Biomolecular Screening|April 23, 2013
Development of a colorimetric and a fluorescence phosphatase-inhibitor assay suitable for drug discovery approachesHannieh Sotoud, Philip Gribbon, Bernhard Ellinger, et al.
Scientific Reports|February 16, 2026
APOL1 plasma membrane pools resist rapid protein degradationVerena Höffken, Laura Alvermann, David Niggemeier, et al.
Chembiochem : a European Journal of Chemical Biology|October 24, 2013
Iterative antimicrobial candidate selection from informed d-/l-Peptide dimer librariesRoman J Lichtenecker, Bernhard Ellinger, Hong-Mei Han, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Expert Opinion on Drug Discovery|February 20, 2016
Risk mitigation in academic drug discoveryBernhard Ellinger, Philip Gribbon
Chembiochem : a European Journal of Chemical Biology|December 17, 2008
A fluorescent probe for the 70 S-ribosomal GTPase-associated centerSebastian Schoof, Sascha Baumann, Bernhard Ellinger, et al.
Angewandte Chemie (International Ed. in English)|April 21, 2007
Generation of live-cell microarrays by means of DNA-Directed immobilization of specific cell-surface ligandsHendrik Schroeder, Bernhard Ellinger, Christian F W Becker, et al.
Bioorganic & Medicinal Chemistry|March 7, 2008
ATP competitive inhibitors of D-alanine-D-alanine ligase based on protein kinase inhibitor scaffoldsGemma Triola, Stefan Wetzel, Bernhard Ellinger, et al.
Journal of the American Chemical Society|February 13, 2010
Synthesis and structure-activity correlation of natural-product inspired cyclodepsipeptides stabilizing F-actinRené Tannert, Lech-Gustav Milroy, Bernhard Ellinger, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 1, 2022
High-throughput drug screening allowed identification of entry inhibitors specifically targeting different routes of SARS-CoV-2 Delta and Omicron/BA.1Maria Kuzikov, Jannis Woens, Andrea Zaliani, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 19, 2011
Biology-oriented synthesis of a natural-product inspired oxepane collection yields a small-molecule activator of the Wnt-pathwaySudipta Basu, Bernhard Ellinger, Stefano Rizzo, et al.
Journal of Biomolecular Screening|April 23, 2013
Development of a colorimetric and a fluorescence phosphatase-inhibitor assay suitable for drug discovery approachesHannieh Sotoud, Philip Gribbon, Bernhard Ellinger, et al.
Scientific Reports|February 16, 2026
APOL1 plasma membrane pools resist rapid protein degradationVerena Höffken, Laura Alvermann, David Niggemeier, et al.
Chembiochem : a European Journal of Chemical Biology|October 24, 2013
Iterative antimicrobial candidate selection from informed d-/l-Peptide dimer librariesRoman J Lichtenecker, Bernhard Ellinger, Hong-Mei Han, et al.
Pageof 6